More cost-effective cure for hepatitis C may be close
Tuesday, March 22, 2016 - 18:30
in Health & Medicine
The cost of treating hepatitis C virus (HCV) could be cut up to 50 percent if mathematical models are used to predict when patients can safely stop taking direct-acting antiviral (DAA) medication, according to a new study by researchers at Loyola University Health System and Loyola University Chicago.